|
G2E3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.24879999999317E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73170000000012E-05 |
| Normal-vs-Stage2 |
3.077100E-03 |
| Normal-vs-Stage3 |
1.47630000002508E-07 |
| Normal-vs-Stage4 |
5.516800E-03 |
| Stage1-vs-Stage2 |
8.110200E-01 |
| Stage1-vs-Stage3 |
1.974020E-02 |
| Stage1-vs-Stage4 |
6.092200E-01 |
| Stage2-vs-Stage3 |
2.023400E-01 |
| Stage2-vs-Stage4 |
7.812600E-01 |
| Stage3-vs-Stage4 |
4.933400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53293999999304E-05 |
| Normal-vs-AfricanAmerican |
2.91919999950707E-07 |
| Normal-vs-Asian |
3.574000E-01 |
| Caucasian-vs-AfricanAmerican |
4.116000E-02 |
| Caucasian-vs-Asian |
5.406000E-01 |
| AfricanAmerican-vs-Asian |
8.700300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.25170000001107E-06 |
| Normal-vs-Female |
6.08020000000264E-05 |
| Male-vs-Female |
4.671800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.256080E-03 |
| Normal-vs-Age(41-60Yrs) |
1.375090E-03 |
| Normal-vs-Age(61-80Yrs) |
6.21469997685864E-09 |
| Normal-vs-Age(81-100Yrs) |
1.648630E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.210000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.506600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.176200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.244100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.338400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.884200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.801800E-01 |
| Normal-vs-Grade 2 |
2.616200E-03 |
| Normal-vs-Grade 3 |
1.57470037009944E-10 |
| Normal-vs-Grade 4 |
1.917460E-03 |
| Grade 1-vs-Grade 2 |
4.906000E-01 |
| Grade 1-vs-Grade 3 |
1.896110E-02 |
| Grade 1-vs-Grade 4 |
7.221800E-02 |
| Grade 2-vs-Grade 3 |
1.022030E-03 |
| Grade 2-vs-Grade 4 |
1.646370E-01 |
| Grade 3-vs-Grade 4 |
9.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.500300E-03 |
| Normal-vs-ccB subtype |
1.06250000020403E-07 |
| ccA subtype-vs-ccB subtype |
1.115790E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.760800E-04 |
| Normal-vs-N1 |
8.10250000000678E-05 |
| N0-vs-N1 |
8.918300E-03 |
|
|
